Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - Alliances
Nordic Nanovector And Affibody Collaborate On New Advanced Radio-Immunotherapies Program For Multiple Myeloma 11/26/2014 2:10:22 PM
IXICO Announces Enhanced Contracts With Two Pharmaceutical Company Customers In Huntington's Disease 11/26/2014 1:50:50 PM
University of California, San Francisco (UCSF) And OncoSec Medical Inc. Collaborate To Evaluate Investigational Combination Of ImmunoPulse And Anti-PD-1 Treatment 11/25/2014 10:36:55 AM
$1 Billion Oncology Alliance Between Menarini Group & Oxford BioTherapeutics Initiates First-In-Human Study Of Enhanced Antibody For Treatment Of Acute Myeloid Leukemia 11/25/2014 5:41:30 AM
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With Pharmaceutics International, Inc. 11/25/2014 1:55:13 PM
Zymeworks Announces Research Collaboration With Dr. Dennis J. Slamon And University of California, Los Angeles (UCLA) 11/25/2014 9:57:00 AM
Paragon Bioservices Wins NIH Contract For Design & Scale-Up Manufacturing Of rhE -Selectin Protein 11/25/2014 9:24:16 AM
Parent Project Muscular Dystrophy And Santhera Pharmaceuticals AG (SANN.SW) Team Up On Benefit/Risk Study In Duchenne 11/25/2014 9:22:00 AM
Omnicare, Inc. (OCR) And McKesson Corporation Expand Distribution Agreement 11/24/2014 7:17:02 AM
Trimel Pharmaceuticals (TRL.TO), Endo International (ENDP) Ink NATESTO Deal For Up To $195M 11/24/2014 5:46:23 AM
GlaxoSmithKline (GSK) Shareholders To Vote On Novartis AG (NVS) Deal On Dec. 18 11/24/2014 6:07:32 AM
Drug Giant Merck & Co. (MRK) Buys Rights To NewLink Genetics Ebola Vaccine rVSV-EBOV 11/24/2014 5:48:37 AM
Bristol-Myers Squibb Company (BMY) And Five Prime Therapeutics, Inc. (FPRX) Announce Exclusive Clinical Collaboration To Evaluate The Combination Of Investigational Immunotherapies Opdivo (nivolumab) And FPA008 In Six Tumor Types 11/24/2014 8:44:55 AM
Chembio Diagnostics, Inc. (CEMI.OB) Signs Agreement With CDC Contractor To Develop A Multiplex Point-Of-Care Test For Influenza Immunity 11/24/2014 1:34:32 PM
MRC Technology And Yabao Pharmaceuticals Announce Exclusive Partnership In China To Develop Novel Therapeutics For Parkinson’s Disease 11/24/2014 12:00:28 PM
1234567
//-->